Last reviewed · How we verify

NCT01224158

Study of an Experimental Toothbrush for Treatment and Prevention of Gingivitis

Completed NA Results posted Last updated 4 December 2019
What this trial tests

NA trial testing Experimental Power Toothbrush in Dental Devices, Home Care in 153 participants. Completed in 29 October 2010.

Timeline
13 September 2010
Primary endpoint
29 October 2010
29 October 2010

Quick facts

Lead sponsorJohnson & Johnson Consumer and Personal Products Worldwide
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment153
Start date13 September 2010
Primary completion29 October 2010
Estimated completion29 October 2010
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Johnson & Johnson Consumer and Personal Products Worldwide — full company profile →

Who can join

18 and older, any sex, with Dental Devices, Home Care. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Whole-mouth Mean Modified Gingival Index (MGI) Score at Day 42 Primary · Day 42

Gingivitis was assessed by the Modified Gingival Index on the buccal and lingual marginal gingiva and interdental papillae of all scorable teeth by the dental examiner using following scale score range from 0 to 4, where 0 - Normal (absence of inflammation); 1 - Mild inflammation (slight change in color, little change in texture) of any portion of the gingival unit; 2 - Mild inflammation of the entire gingival unit; 3 - Moderate inflammation (moderate glazing, redness, edema, and/or hypertrophy) of the gingival unit; 4 - Severe inflammation (marked redness and edema/hypertrophy, spontaneous bl

GroupValue95% CI
Manual Toothbrush (PR-000172)1.880± 0.1223
Power Toothbrush (PR-009577)1.770± 0.1443
Whole-mouth Mean Modified Gingival Index (MGI) Score at Day 28 Secondary · Day 28

Gingivitis was assessed by the Modified Gingival Index on the buccal and lingual marginal gingiva and interdental papillae of all scorable teeth by the dental examiner using following scale with score range from 0 to 4, where 0 - Normal (absence of inflammation); 1 - Mild inflammation (slight change in color, little change in texture) of any portion of the gingival unit; 2 - Mild inflammation of the entire gingival unit; 3 - Moderate inflammation (moderate glazing, redness, edema, and/or hypertrophy) of the gingival unit; 4 - Severe inflammation (marked redness and edema/hypertrophy, spontaneo

GroupValue95% CI
Manual Toothbrush (PR-000172)1.957± 0.1225
Power Toothbrush (PR-009577)1.868± 0.1287
Whole-mouth Mean Rustogi Modified Navy Plaque Index (RMNPI) Score at Day 42 Secondary · Day 42

Supra-gingival plaque was assessed on the facial and lingual surfaces of the teeth (7-7 each arch) using the RMNPI. The facial and lingual surfaces were divided into nine unequal segments, as follows, for a total of 18 sites per tooth: A-C along the gingival margin; D and F (inter-proximal zones) directly above A-C; G-H across the middle of the tooth and I covers the incisal area. Plaque was assigned on one of the following score: 0 represents no dental plaque and 1 represents plaque present in the measured segment of the tooth. Mean RMNPI overall was calculated for each participant as the tot

GroupValue95% CI
Manual Toothbrush (PR-000172)0.146± 0.0710
Power Toothbrush (PR-009577)0.131± 0.0633
Whole-Mouth Mean Rustogi Modified Navy Plaque Index (RMNPI) Score at Day 28 Secondary · Day 28

Supra-gingival plaque was assessed on the facial and lingual surfaces of the teeth (7-7 each arch) using the RMNPI. The facial and lingual surfaces were divided into nine unequal segments, as follows, for a total of 18 sites per tooth: A-C along the gingival margin; D and F (inter-proximal zones) directly above A-C; G-H across the middle of the tooth and I covers the incisal area. Plaque was assigned on one of the following score: 0 represents no dental plaque and 1 represents plaque present in the measured segment of the tooth. Mean RMNPI overall was calculated for each participant as the tot

GroupValue95% CI
Manual Toothbrush (PR-000172)0.164± 0.0755
Power Toothbrush (PR-009577)0.148± 0.0762
Hard-to-reach Mean Rustogi Modified Navy Plaque Index (RMNPI) at Day 28 and 42 Secondary · Day 28 and 42

Hard-to-reach mean score is defined as mean of scores over following areas combined; a) Gingival margin (Sites A - C); b) Distal Molars (F for teeth 2, 15, 18, and 31 or the most posterior molar in that quadrant); c) Lingual of the mandibular incisors (Teeth 23-26, lingual); d) Interproximal (Sites D and F); e) Mandibular posterior lingual (Teeth 18-21, 28-31, lingual). Supra-gingival plaque was assessed on facial and lingual surfaces of teeth (7-7 each arch) using the RMNPI. The facial and lingual surfaces were divided into nine unequal segments, as follows, for a total of 18 sites per tooth:

Day 28
GroupValue95% CI
Manual Toothbrush (PR-000172)0.232± 0.1066
Power Toothbrush (PR-009577)0.209± 0.1067
Day 42
GroupValue95% CI
Manual Toothbrush (PR-000172)0.208± 0.0993
Power Toothbrush (PR-009577)0.186± 0.0905
Mean Rustogi Modified Navy Plaque Index (RMNPI) at Day 28 and 42 for Each Hard-to-reach Area Secondary · Day 28 and 42

Hard-to-reach mean score is defined as mean of scores over following areas separately d; a) Gingival margin (Sites A - C); b) Distal Molars (F for teeth 2, 15, 18, and 31 or the most posterior molar in that quadrant); c) Lingual of the mandibular incisors (Teeth 23-26, lingual); d) Interproximal (Sites D and F); e) Mandibular posterior lingual (Teeth 18-21, 28-31, lingual). Supra-gingival plaque was assessed on facial and lingual surfaces of teeth (7-7 each arch) using the RMNPI. The facial and lingual surfaces were divided into nine unequal segments, as follows, for a total of 18 sites per to

Gingival Margin: Day 28
GroupValue95% CI
Manual Toothbrush (PR-000172)0.298± 0.1172
Power Toothbrush (PR-009577)0.271± 0.1169
Gingival Margin: Day 42
GroupValue95% CI
Manual Toothbrush (PR-000172)0.273± 0.1181
Power Toothbrush (PR-009577)0.246± 0.0992
Distal Molars: Day 28
GroupValue95% CI
Manual Toothbrush (PR-000172)0.413± 0.2599
Power Toothbrush (PR-009577)0.399± 0.2175
Distal Molars: Day 42
GroupValue95% CI
Manual Toothbrush (PR-000172)0.352± 0.2172
Power Toothbrush (PR-009577)0.339± 0.2284
Lingual of the Mandibular Incisors: Day 28
GroupValue95% CI
Manual Toothbrush (PR-000172)0.190± 0.2501
Power Toothbrush (PR-009577)0.149± 0.2430
Lingual of the Mandibular Incisors: Day 42
GroupValue95% CI
Manual Toothbrush (PR-000172)0.152± 0.1892
Power Toothbrush (PR-009577)0.119± 0.2035
Interproximal: Day 28
GroupValue95% CI
Manual Toothbrush (PR-000172)0.195± 0.1173
Power Toothbrush (PR-009577)0.169± 0.1122
Interproximal: Day 42
GroupValue95% CI
Manual Toothbrush (PR-000172)0.171± 0.1047
Power Toothbrush (PR-009577)0.148± 0.1054

Sponsor's own description

This study is 6 weeks long with 6 visits to a clinical site. People participating in this study will be asked to brush their teeth two times a day with a provided toothbrush. For one of those six weeks people will be asked to rinse with a mouthwash. During that time, people will use the mouthwash two times a day and will not be allowed to brush their teeth at all. The mouth, teeth, tongue and gums will be looked at by a dentist. At each visit, people will rinse with a pink liquid that will dye their mouths pink. The dye is temporary and will go away by the end of the day. They may also be asked to complete a short questionnaire about their experience.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Johnson & Johnson Consumer and Personal Products Worldwide trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01224158.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing